Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Lipid Metabolism on Antitumor Immune Response.
Mabrouk N, Lecoeur B, Bettaieb A, Paul C, Végran F. Mabrouk N, et al. Among authors: vegran f. Cancers (Basel). 2022 Apr 6;14(7):1850. doi: 10.3390/cancers14071850. Cancers (Basel). 2022. PMID: 35406621 Free PMC article. Review.
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.
Dosset M, Vargas TR, Lagrange A, Boidot R, Végran F, Roussey A, Chalmin F, Dondaine L, Paul C, Lauret Marie-Joseph E, Martin F, Ryffel B, Borg C, Adotévi O, Ghiringhelli F, Apetoh L. Dosset M, et al. Among authors: vegran f. Oncoimmunology. 2018 Mar 15;7(6):e1433981. doi: 10.1080/2162402X.2018.1433981. eCollection 2018. Oncoimmunology. 2018. PMID: 29872568 Free PMC article.
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rébé C, Paul C, Végran F, Ghiringhelli F. Bruchard M, et al. Among authors: vegran f. Nat Immunol. 2022 Feb;23(2):262-274. doi: 10.1038/s41590-021-01120-y. Epub 2022 Jan 31. Nat Immunol. 2022. PMID: 35102345
Alternative Splicing in Cancer and Immune Cells.
Bernard A, Boidot R, Végran F. Bernard A, et al. Among authors: vegran f. Cancers (Basel). 2022 Mar 28;14(7):1726. doi: 10.3390/cancers14071726. Cancers (Basel). 2022. PMID: 35406498 Free PMC article. Review.
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.
Mabrouk N, Racoeur C, Shan J, Massot A, Ghione S, Privat M, Dondaine L, Ballot E, Truntzer C, Boidot R, Hermetet F, Derangère V, Bruchard M, Végran F, Chouchane L, Ghiringhelli F, Bettaieb A, Paul C. Mabrouk N, et al. Among authors: vegran f. Cancers (Basel). 2023 Jun 9;15(12):3129. doi: 10.3390/cancers15123129. Cancers (Basel). 2023. PMID: 37370739 Free PMC article.
64 results